Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 20202020년 여름 오스트리아 티롤 주의 건강한 헌혈자에서 SARS-CoV-2 항체의 유행Observational Study Published on 2021-10-262022-09-12 Journal: Wiener Klinische Wochenschrift [Category] MERS, SARS, 임상, 진단, [키워드] 95% CI 95% confidence interval Abbott acute respiratory syndrome acute respiratory syndrome coronavirus age antibody association Blood blood donor Blood donors Characteristics Cohort COVID-19 cross-sectional Cross-sectional studies determine District Donor Epidemiology female finding fold Gender health authorities Health authority healthy blood donor healthy blood donors IgG immunoassay individual Landeck Local Logistic regression Loss of Smell medication Microparticle not differ Observational cohort study Odds ratio participant reported SARS-CoV-2 antibody SARS-CoV‑2 SARS-CoV‑2 infection screened seronegative seropositive participant seropositive participants Seropositivity Seroprevalence severe acute respiratory syndrome Coronavirus Spread summer Symptoms Taste tested Travel Variation [DOI] 10.1007/s00508-021-01963-3 PMC 바로가기 [Article Type] Observational Study
Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in ArizonaResearch Published on 2021-10-222022-10-30 Journal: JAMA Health Forum [Category] COVID-19, MERS, SARS, [키워드] 95% CI adjusted age Analysis Care Cohort cohort study Community comparable confounder confounding factors Contact COVID-19 COVID-19 pandemic COVID-19 vaccine defined elevated Enrollment Essential essential worker Essential workers exposure finding first positive generate greater Guidance Health Health status Hispanic Importance incidence incidence rate individuals Infection infection risk measure multivariable model nasal swab negative objective operator Other participant performed Point polymerase chain prevaccination prospective cohort study PROTECT public health real-time reverse transcriptase Relevance remained Research Responder responders Result risk SARS-CoV-2 SARS-COV-2 infection seronegative setting significantly higher Sociodemographic characteristics specimen study cohort submitted understanding was used while white worker [DOI] 10.1001/jamahealthforum.2021.3318 PMC 바로가기 [Article Type] Research
Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in DenmarkResearch Article Published on 2021-10-202022-10-30 Journal: Microbiology Spectrum [Category] COVID-19, MERS, SARS, [키워드] 95% CI 95% confidence interval acute respiratory syndrome age applied Asymptomatic asymptomatic infections being BMI body mass index Capital coronavirus COVID-19 Cox proportional hazard Denmark effort ELISA enzyme-linked immunosorbent Factor female hazard ratio HCW Health care worker health care workers independent risk factor individual Infection interquartile range Kaplan-Meier method median mild infection MOST multivariable model National PCR PCR-confirmed performed positive PCR presence of antibody Probability prospective cohort study PROTECT reduce Region Reinfection risk risk factor Risk factors SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2 RNA screened Seroconversion seroconvert serology seronegative seropositive study period total antibodies worker [DOI] 10.1128/Spectrum.00904-21 PMC 바로가기 [Article Type] Research Article
Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case–control studyOriginal Article Published on 2021-10-042022-11-01 Journal: Clinical microbiology and infection : the official [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 95% CI Acral manifestations activity age Algorithm Analysis association chilblain chilblains clearance Control COVID-19 COVID-19 pandemic effective FIVE healthy volunteer hospital hospitals household Humoral immunity Immunological response individual individuals lockdown multicentre objective offered participant pernio Perniosis positive serology raised recruited reported Result resulting RT-PCR RT-PCR testing SARS-CoV-2 SARS-COV-2 infection serological test serology seronegative Symptoms tested the SARS-CoV-2 [DOI] 10.1016/j.cmi.2021.09.032 PMC 바로가기 [Article Type] Original Article
IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infectionSARS-CoV-2 감염 후 뉴클레오캡시드 및 스파이크 단백질에 대한 IgG 항체 반응Observational Study Published on 2021-10-012022-09-11 Journal: Infection [Category] MERS, SARS, 임상, 진단, 치료법, [키워드] Abbott antibody Architect Chain Reaction changes in collected Complete Concentration coronavirus coronavirus disease Coronavirus disease-19 COVID-19 enrolment epidemiological Follow-up Frequency growth help IgG IgG antibody individual Infection magnitude neutralising nucleocapsid nucleocapsid antigen nucleocapsid protein Observational cohort study pandemic persistence platform polymerase chain reaction positive Protein public health quantitative assay real-time reverse transcriptase-polymerase chain reaction recorded remained reverse transcriptase reverse transcriptase-polymerase chain reaction Roche RT-qPCR SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection sera seronegative seropositive serum sample serum samples spike Spike protein tested titre virus [DOI] 10.1007/s15010-021-01651-4 PMC 바로가기 [Article Type] Observational Study
The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay사전 및 사후 부스터 BNT162b2 항 SARS-CoV-2 항체 수준 간의 연관성 강도는 면역 분석에 따라 다릅니다.Observational Study Published on 2021-10-012022-09-12 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 임상, 진단, [키워드] age anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibodies association baseline BNT162b2 BNT162b2 vaccine booster clinical effectiveness commercial immunoassay coronavirus disease correlation COVID-19 determine dose Elecsy enrolled Evidence females healthcare worker highest homologous humoral IgG immunoassay immunoassays initial LIAISON Pearson predicted Roche S-RBD SARS-CoV-2 SARS-CoV-2 IgG second dose seronegative serum serum antibody significantly the immunoassay vaccination Vaccine vaccine dose were assessed [DOI] 10.1016/j.ijid.2021.08.059 PMC 바로가기 [Article Type] Observational Study
A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children불량하고 지연된 항-SARS-CoV2 IgG 반응은 어린이의 심각한 COVID-19와 관련이 있습니다Observational Study Published on 2021-10-012022-09-12 Journal: EBioMedicine [Category] MERS, SARS, 임상, 진단, [키워드] acute infection acute phase acute respiratory syndrome Admission analyzed antibodies antibody Antibody Response Asymptomatic Asymptomatic disease children circulating Cohort Comorbidity convalescent coronavirus COVID-19 detectable develop disease disease severity Disease severity, antibodies, T cells Frequency had no IgG and IgM IgG response Infection Inflammatory Inflammatory cytokines kinetic Mild MIS-C moderate disease MOST outcome Patient pediatric pediatric COVID-19 plasma concentration Plasma cytokine plasmablast prevalent pro-inflammatory promotion SARS-CoV-2 seronegative severe COVID-19 severe disease severity stratified syndrome T helper cell the spike protein [DOI] 10.1016/j.ebiom.2021.103615 PMC 바로가기 [Article Type] Observational Study
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis PatientsObservational Study Published on 2021-10-012022-10-05 Journal: American journal of kidney diseases : the official [Category] 임상, [키워드] activated acute respiratory syndrome age analyzed antibody Antibody Response Antigen approaches association Barcelona baseline BNT162b2 CD4 cellular Cellular immune response cellular immunity cellular response characterized Clinical outcome comparable coronavirus coronavirus disease COVID-19 COVID-19 vaccines defined dialysis effective vaccine End-stage renal disease End-stage renal disease (ESRD) evaluate evaluated General population Health health authorities Hemodialysis high risk higher risk humoral Humoral response IgG IgG antibody IgG level immunization immunogenicity Immunosuppression Immunosuppressive treatment Infection kidney Laboratory Logistic Messenger RNA Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 multicenter cohort study Multiple linear regression multivariable Patient patients patients treated Pfizer-BioNTech positive response proportion rationale receiving reported response SARS-CoV-2 SARS-CoV-2 vaccine secondary outcome Seroconversion seroconverted seronegative setting Spain study outcomes T cell tested the receptor-binding domain vaccination vaccine administration were used [DOI] 10.1053/j.ajkd.2021.06.002 PMC 바로가기 [Article Type] Observational Study
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study자가면역 염증성 류마티스 질환 성인 환자 및 일반 인구에서 BNT162b2 mRNA COVID-19 백신의 면역원성과 안전성: 다기관 연구Observational Study Published on 2021-10-012022-09-12 Journal: Annals of the rheumatic diseases [Category] MERS, SARS, 임상, 진단, [키워드] adverse event Autoimmune binding antibody unit biological therapy BNT162b2 mRNA BNT162b2 mRNA vaccine Control control group COVID-19 COVID-19 pandemic COVID-19 vaccine death defined Disease activity Efficacy evaluated Factor General population Glucocorticoids herpes zoster IgG IgG antibody IgG level immunogenic immunogenicity Inflammatory Major majority Messenger RNA methotrexate Mild MMF mRNA multicentre Older age Patient patients postvaccination Protein reduced remained rheumatic disease rituximab S1/S2 safety profile SARS-CoV-2 spike seronegative Seropositivity significantly significantly lower symptomatic case Treatment two-dose regimen vaccination Vaccine vaccine dose were assessed were measured [DOI] 10.1136/annrheumdis-2021-220647 PMC 바로가기 [Article Type] Observational Study
Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose스푸트니크 V 백신에 대한 면역글로불린 G 항체 반응: 이전에 SARS-CoV-2 혈청 양성 반응을 보인 개인은 단 한 번의 백신 접종이 필요할 수 있습니다.Article Published on 2021-10-012022-09-11 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, 치료법, [키워드] antibody antibody levels Antibody Response antibody response against Antibody responses booster dose Cohort develop domain dose doses enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated had no IgG IgG antibodies IgG antibody IgG immune response IgG response Immunoglobulin Immunoglobulin G individual individuals nucleocapsid protein nucleocapsid protein (NP) RBD receiving Receptor-binding domain Receptor-binding domain (RBD) S/P S/P ratio SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens second dose seronegative seropositive seropositive individual seropositive subject seropositive subjects significant increase Spike protein Sputnik V vaccine the receptor-binding domain the spike protein the vaccine triggered vaccination Vaccine vaccine booster dose. vaccine dose Venezuela [DOI] 10.1016/j.ijid.2021.07.070 PMC 바로가기 [Article Type] Article